Entia Biosciences, Inc. (ERGO)

Market Cap	34.06K +400.0%
Revenue (ttm)	265.47K -23.5%
Net Income	-1.40M
EPS	-0.05
Shares Out	34.06M
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	550
Open	0.0010
Previous Close	0.0002
Day's Range	0.0010 - 0.0010
52-Week Range	0.0001 - 0.0402
Beta	30.46
Analysts	n/a
Price Target	n/a
Earnings Date	n/a

About Entia Biosciences

Entia Biosciences, Inc. engages in the development, production, and distribution of dietary supplements, nutraceuticals, and medical food products in the United States. The company develops ErgoD2, a pharmaceutical grade organic compound for the improvement of iron homeostasis and mitigation of iron-related disorders presenting in anemia, chronic kidney disease, and select neurodegenerative diseases. It is also involved in the discovery, scientific evaluation, and marketing of natural formulations that can be used in medical food, nutraceutical...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 7
• Stock Exchange: OTCMKTS
• Ticker Symbol: ERGO

Data Source: S&P Global Market Intelligence

Fundamental and historical data is provided by S&P Global Market Intelligence.

Last checked:

Nov 10, 2026

Data Sources Report a data error